MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-10-2025
FONAR Corporation Total Liabilities 2011-2025 | FONR
Annual Total Liabilities FONAR Corporation
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 53.1 M | 54.1 M | 54 M | 15.4 M | 16.1 M | 15.9 M | 24.1 M | 25.7 M | 30.9 M | 35.4 M | 22.5 M | 25.7 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 54.1 M | 15.4 M | 31.1 M |
Quarterly Total Liabilities FONAR Corporation
| 2025-Q3 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 57 M | 54.7 M | 49 M | 53.5 M | 52.6 M | 46 M | 47.5 M | 48.7 M | 49.4 M | 50.9 M | 53.1 M | 51.4 M | 51.3 M | 48.8 M | 54.1 M | 54.1 M | 50.3 M | 53.2 M | 54 M | 54 M | 46.6 M | 44 M | 15.4 M | 15.4 M | 13 M | 13.3 M | 16.1 M | 16.1 M | 15.2 M | 15.4 M | 15.9 M | 15.9 M | 19.3 M | 20.5 M | 24.1 M | 24.1 M | 24.8 M | 26 M | 25.7 M | 25.7 M | 28.8 M | 30.7 M | 30.9 M | 30.9 M | 35 M | 35.3 M | 35.4 M | 35.4 M | 22.7 M | 22.8 M | 22.5 M | 22.5 M | 24.3 M | 25.7 M | 25.7 M | 25.7 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 57 M | 13 M | 34.3 M |
Total Liabilities of other stocks in the Medical devices industry
| Issuer | Total Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
GenMark Diagnostics, Inc.
GNMK
|
129 M | - | - | $ 1.77 B |  USA |
 |
Abiomed
ABMD
|
165 M | - | - | $ 17.2 B | USA |
 |
Acutus Medical
AFIB
|
54.8 M | - | -26.83 % | $ 2.62 M | USA |
 |
Apyx Medical Corporation
APYX
|
52.3 M | $ 3.82 | -1.04 % | $ 132 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
5.95 M | - | -5.86 % | $ 30.6 M | USA |
 |
Bio-Rad Laboratories
BIO
|
2.79 B | $ 307.08 | -0.33 % | $ 8.66 B | USA |
 |
Apollo Endosurgery
APEN
|
77.6 M | - | - | $ 475 M | USA |
 |
BioSig Technologies
BSGM
|
2.26 M | - | 37.08 % | $ 85.7 M | USA |
 |
Bruker Corporation
BRKR
|
3.99 B | $ 45.69 | 1.24 % | $ 6.81 K | USA |
 |
Allied Healthcare Products
AHPI
|
3.56 M | - | 3.58 % | $ 2.21 M | USA |
 |
Abbott Laboratories
ABT
|
36.6 B | $ 128.67 | 2.55 % | $ 224 B | USA |
 |
Boston Scientific Corporation
BSX
|
16.7 B | $ 91.95 | -0.67 % | $ 135 B | USA |
 |
Conformis
CFMS
|
39.9 M | - | - | $ 16.4 M | USA |
 |
CryoLife, Inc.
CRY
|
461 M | - | -4.14 % | $ 702 M | USA |
 |
EDAP TMS S.A.
EDAP
|
45.2 M | $ 3.18 | 10.56 % | $ 119 M |  France |
 |
Cardiovascular Systems
CSII
|
73.2 M | - | 0.15 % | $ 844 M | USA |
 |
Cutera
CUTR
|
518 M | - | -10.19 % | $ 1.99 M | USA |
 |
Soliton, Inc.
SOLY
|
2.82 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
3.44 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
21.1 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
57.2 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
14 M | - | - | $ 111 M |  Canada |
 |
Eargo
EAR
|
31.2 M | - | - | $ 10.2 M | USA |
 |
Dynatronics Corporation
DYNT
|
12.2 M | - | 14.99 % | $ 929 K | USA |
 |
Intersect ENT, Inc.
XENT
|
160 M | - | - | $ 955 M | USA |
 |
Cognyte Software Ltd.
CGNT
|
281 M | $ 9.58 | -2.84 % | $ 688 M | Israel |
 |
InMode Ltd.
INMD
|
81.9 M | $ 14.35 | -1.1 % | $ 1.14 B | Israel |
 |
IRIDEX Corporation
IRIX
|
24.9 M | $ 0.99 | 7.52 % | $ 16 M | USA |
 |
IRadimed Corporation
IRMD
|
11.5 M | $ 96.99 | 0.79 % | $ 1.23 B | USA |
 |
Second Sight Medical Products
EYES
|
24 M | - | -0.97 % | $ 54.4 M | USA |
 |
Align Technology
ALGN
|
2.36 B | $ 163.04 | -1.44 % | $ 12.2 B | USA |
 |
Accuray Incorporated
ARAY
|
389 M | $ 1.04 | -2.06 % | $ 107 M | USA |
 |
Avinger
AVGR
|
20 M | - | -20.74 % | $ 369 K | USA |
 |
ClearPoint Neuro
CLPT
|
13.8 M | $ 12.5 | -1.66 % | $ 338 M | USA |
 |
AxoGen
AXGN
|
99.8 M | $ 30.0 | -1.3 % | $ 1.33 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
89.2 M | - | - | $ 3.31 B | USA |
 |
GBS
GBS
|
5.44 M | - | -0.57 % | $ 7.12 M | USA |
 |
CONMED Corporation
CNMD
|
1.34 B | $ 40.3 | -1.29 % | $ 1.24 B | USA |
 |
LivaNova PLC
LIVN
|
1.19 B | $ 63.28 | 0.84 % | $ 3.43 B |  Britain |
 |
OrthoPediatrics Corp.
KIDS
|
119 M | $ 17.83 | 1.31 % | $ 411 M | USA |
 |
Globus Medical
GMED
|
1.07 B | $ 86.73 | 0.05 % | $ 11.8 B | USA |
|
LENSAR
LNSR
|
47.7 M | $ 11.51 | -0.04 % | $ 133 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
2.49 B | $ 13.51 | 0.67 % | $ 1.04 B | USA |
 |
Aziyo Biologics
AZYO
|
82 M | - | 1.37 % | $ 20.5 M | USA |
 |
Alphatec Holdings
ATEC
|
126 M | $ 19.79 | -0.85 % | $ 2.83 B | USA |
 |
Aethlon Medical
AEMD
|
2.24 M | $ 3.07 | -9.71 % | $ 4.79 M | USA |
 |
Establishment Labs Holdings
ESTA
|
294 M | $ 72.39 | -0.17 % | $ 2.04 B |  Costa-rica |